Please join us in the Boston office of Foley & Lardner LLP, together with the Hellenic Innovation Network, on Wednesday, May 4 @ 5:30 p.m. ET for an exciting in-person event, “Frontiers in Life Sciences, the Greek Connection.” The program will include a Fireside Chat with Michel Vounatsos, CEO of Biogen and Nicholas Galakatos, Global Head of Life Sciences at Blackstone, and will be moderated by Anna Protopapas, CEO of Mersana Therapeutics.
Following the discussion, Greek entrepreneurs will pitch their startups, which are fundraising for US expansion.
A cocktail networking reception will follow.
Event Agenda:
- 5:30-6:00 – Networking Reception
- 6:00-7:15 – Fireside Chat, Pitches, Achievement Awards
- 7:15 – 8:30 – Cocktail Networking Reception
To view the invitation and RSVP, please click here.
People
Related Insights
01 July 2024
Innovative Technology Insights
Tailoring Compliance Before AI Walks The Runway
Whether AI will replace human fashion models is a question that has been buzzing around the modeling industry.
01 July 2024
Health Care Law Today
What Does the End of Chevron Deference Mean for Federal Health Care Programs?
On June 28, 2024, the Supreme Court rejected the doctrine of Chevron deference in the closely watched case of Loper Bright Enterprises v. Raimondo.
28 June 2024
Viewpoints
U.S. Supreme Court Rules SEC Must Try Securities Fraud Cases in Federal Jury Trials Rather than In-House Courts
On June 27, 2024, the U.S. Supreme Court ruled that when the SEC seeks civil penalties against a defendant for securities fraud, the Seventh Amendment entitles the defendant to a jury trial.